Bill

BILL • US HOUSE

HR 1843

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

119th Congress
Introduced by Neal Dunn, Kevin Mullin,

HR 1843 boosts transparency in generic drug applications, ensuring clearer info on equivalence for manufacturers, improving access to reliable, affordable medications for consumers.

Introduced in House
0
0

Start the Conversation

Be the first to share your thoughts on this petition. Your voice matters!

Share your opinion above